| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President R&D
3 companies
Dolsten Mikael is a President R&D at PFIZER INC with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $9.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | A Agilent Technologies, Inc. | Director | Sell | 2,600 | $149.81 | $389,511.20 | -34.3% | -21.3% | - | |
| May 11, 2022 | PFE Pfizer Inc | President R&D | Sell | 63,902 | $49.32 | $3,151,547.14 | -2.7% | +2.3% | -22.1% | |
| Nov 11, 2021 | PFE Pfizer Inc | President R&D | Sale+OE | 59,664 | $50.29 | $3,000,646.92 | -2.6% | +3.4% | -2.1% |